CJC-1295 with DAC is a potent growth hormone secretagogue and a modified version of the first 29 amino acids of GHRH (known as Mod GRF 1-29). This tetrasubstituted peptide has been chemically altered for increased stability.

The key feature of this compound is the addition of the Drug Affinity Complex (DAC). This complex consists of a lysine residue linked to a maleimidopropionic acid group, which allows the peptide to covalently bind to circulating albumin in the bloodstream. This binding protects the peptide from rapid degradation by enzymes, extending its biological half-life from minutes (like natural GHRH) to approximately 6-8 days.

By stimulating the GHRH receptors in the anterior pituitary, CJC-1295 with DAC promotes the steady, long-term release of endogenous growth hormone and, consequently, increases levels of Insulin-Like Growth Factor 1 (IGF-1). It is researched for its potential to increase protein synthesis, muscle mass, and fat loss (lipolysis) without the large, unnatural spikes in GH caused by other secretagogues.

Chemical & Physical Properties:

• Product: CJC-1295 with DAC

• Quantity: 2 mg

• Appearance: White Lyophilized Powder

• Molecular Formula: C₁₆₅H₂₇₀N₄₇O₄₆

• Molecular Weight: 3648.4 g/mol

• Amino Acid Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH₂

• Purity: Typically ≥98% (via HPLC)

• Storage: Store lyophilized powder at -20°C. Once reconstituted, store in a refrigerator at 2-8°C.

• CAS Number: 863288-34-0

For Research Use Only. This product is not intended for diagnostic, therapeutic, or human use.